Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China
· Delayed Price · Currency is CNY 23.15
+0.22 (0.96%)
Mar 10, 2026, 10:35 AM CST
SHA:688298 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,430 | 4,527 | 5,666 | 7,209 | 12,955 | 27,660 | Upgrade
|
| Market Cap Growth | -23.67% | -20.12% | -21.40% | -44.35% | -53.16% | 13.55% | Upgrade
|
| Enterprise Value | 2,226 | 2,322 | 2,695 | 2,201 | 5,922 | 22,133 | Upgrade
|
| Last Close Price | 22.93 | 23.43 | 29.33 | 35.76 | 61.58 | 127.17 | Upgrade
|
| PE Ratio | - | - | - | - | 6.27 | 5.62 | Upgrade
|
| PS Ratio | 4.62 | 4.72 | 6.84 | 8.79 | 1.48 | 2.72 | Upgrade
|
| PB Ratio | 0.68 | 0.70 | 0.83 | 0.96 | 1.56 | 4.01 | Upgrade
|
| P/TBV Ratio | 0.82 | 0.83 | 0.95 | 1.04 | 1.69 | 4.11 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 6.66 | 5.89 | Upgrade
|
| P/OCF Ratio | - | - | - | - | 4.32 | 5.32 | Upgrade
|
| EV/Sales Ratio | 2.32 | 2.42 | 3.26 | 2.68 | 0.68 | 2.18 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 2.53 | 3.78 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 2.62 | 3.80 | Upgrade
|
| EV/FCF Ratio | - | - | - | - | 3.05 | 4.71 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.07 | 0.08 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.04 | 0.00 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.04 | 0.00 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.41 | -0.61 | -0.92 | -0.91 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.89 | 5.89 | 4.79 | 9.06 | -3.28 | -1.07 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 2.20 | 1.75 | -3.95 | -1.34 | Upgrade
|
| Asset Turnover | - | - | 0.10 | 0.08 | 0.89 | 1.62 | Upgrade
|
| Inventory Turnover | - | - | 2.01 | 1.65 | 11.43 | 6.30 | Upgrade
|
| Quick Ratio | - | - | 2.94 | 5.01 | 3.57 | 3.66 | Upgrade
|
| Current Ratio | - | - | 3.31 | 5.43 | 3.84 | 3.95 | Upgrade
|
| Return on Equity (ROE) | -8.48% | -8.48% | -7.93% | -5.27% | 27.58% | 105.79% | Upgrade
|
| Return on Assets (ROA) | - | - | -5.58% | -4.19% | 14.36% | 57.97% | Upgrade
|
| Return on Invested Capital (ROIC) | -13.85% | -14.13% | -22.02% | -36.79% | 305.18% | 1183.49% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | -11.10% | -8.30% | 26.80% | 84.10% | Upgrade
|
| Earnings Yield | -12.72% | -12.45% | -9.34% | -5.51% | 15.96% | 17.79% | Upgrade
|
| FCF Yield | - | - | -22.45% | -36.64% | 15.01% | 16.98% | Upgrade
|
| Dividend Yield | - | - | - | - | 2.71% | 2.89% | Upgrade
|
| Payout Ratio | - | - | - | - | 35.89% | 10.26% | Upgrade
|
| Buyback Yield / Dilution | 2.19% | 2.19% | 2.56% | -0.13% | 0.02% | -2.16% | Upgrade
|
| Total Shareholder Return | 2.19% | 2.19% | 2.56% | -0.13% | 2.73% | 0.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.